Showing results (261-270 of 301) with videos related to
Sort By:
Pageof 31
Journal of the American Society of Nephrology : JASN|May 25, 2001
Hepatocyte growth factor prevents the development of chronic allograft nephropathy in ratsHaruhito Azuma, Shiro Takahara, Kunio Matsumoto, et al.Asian Pacific Journal of Cancer Prevention : APJCP|April 5, 2016
Prostatic Bleeding after Prostatic Biopsy Effects Oncological Outcomes with Laparoscopic Radical ProstatectomyTomoaki Takai, Teruo Inamoto, Kazumasa Komura, et al.Central European Journal of Urology|June 30, 2026
Enfortumab vedotin demonstrates consistent efficacy in platinum- and ICI-refractory metastatic urothelial carcinoma patients irrespective of prior response: a multicenter real-world studyShunsuke Watanabe, Yuichi Kitagawa, Asuka Uchiyama, et al.Photodiagnosis and Photodynamic Therapy|January 12, 2016
The clinical trial on the safety and effectiveness of the photodynamic diagnosis of non-muscle-invasive bladder cancer using fluorescent light-guided cystoscopy after oral administration of 5-aminolevulinic acid (5-ALA)Keiji Inoue, Hideyasu Matsuyama, Kiyohide Fujimoto, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 5, 2008
Sensitivity to epidermal growth factor receptor inhibitor requires E-cadherin expression in urothelial carcinoma cellsPeter C Black, Gordon A Brown, Teruo Inamoto, et al.Translational Andrology and Urology|September 15, 2025
Upper urinary tract urothelial carcinoma patients show better overall response rate than bladder cancer patients during enfortumab vedotin treatment following pembrolizumabMamoru Hashimoto, Ken Fukiage, Kosei Taniguchi, et al.International Journal of Clinical Oncology|October 1, 2024
Real-world outcomes in patients with metastatic castration-resistant prostate cancer beyond progression after upfront androgen receptor signaling inhibitorYutaka Yamamoto, Saizo Fujimoto, Mamoru Hashimoto, et al.Cancer Medicine|April 8, 2020
Development and external validation of a preoperative nomogram for predicting pathological locally advanced disease of clinically localized upper urinary tract carcinomaTakashi Yoshida, Takashi Kobayashi, Takayuki Kawaura, et al.American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|January 29, 2020
Targeting of intragraft reactive oxygen species by APP-103, a novel polymer product, mitigates ischemia/reperfusion injury and promotes the survival of renal transplantsKoichiro Minami, Soochan Bae, Hirofumi Uehara, et al.Journal of Radiation Research|April 12, 2023
A Japanese registry study and systematic review of particle therapy for renal cell carcinomaHitoshi Ishikawa, Takeshi Arimura, Kazushi Maruo, et al.Pageof 31